Btai analyst ratings
WebApr 10, 2024 · Bioxcel Therapeutics (BTAI) In a report released today, Greg Harrison from Bank of America Securities reiterated a Buy rating on Bioxcel Therapeutics, with a price target of $43.00. The company ... WebMar 31, 2024 · BioXcel Therapeutics Inc. research and ratings by Barron's. View BTAI revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Btai analyst ratings
Did you know?
Web1 day ago · In a report released today, Corinne Jenkins from Goldman Sachs maintained a Hold rating on Bioxcel Therapeutics (BTAI – Research Report). The company’s shares closed yesterday at $16.69. The ... WebMar 24, 2024 · According to 16 stock analysts, the average 12-month stock price …
WebMar 29, 2024 · BTAI Stock Price Targets and Analyst Ratings BioXcel Therapeutics Inc. Stock NASDAQ: BTAI Open Broker Account NASDAQ Stock Exchange > Healthcare > Biotechnology $18.08 (2.15%) Volume: 574.484k Closed: Mar 29, 2024 Score: -4.178 Chart & Forecast Price Targets & Analyst Ratings Earnings Reports Discussion Insider … WebBioXcel Therapeutics Inc. analyst estimates, including BTAI earnings per share …
WebApr 11, 2024 · BioXcel Therapeutics (NASDAQ:BTAI – Get Rating) last posted its … WebView real-time BTAI stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 9 ratings: $52.10. ... Fundamental company data and analyst estimates ...
Web7 rows · Apr 9, 2024 · MarketBeat calculates consensus analyst ratings for stocks …
WebApr 14, 2024 · 70. See BTAI Report. InvestorsObserver is giving BioXcel Therapeutics Inc (BTAI) an Analyst Rating Rank of 73, meaning BTAI is ranked higher by analysts than 73% of stocks. The average price target for BTAI is $101.5 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating BTAI a Strong Buy today. palki processionWebApr 6, 2024 · Analyst Forecast According to 16 analysts, the average rating for BTAI stock is "Buy." The 12-month stock price forecast is $54.52, which is an increase of 215.51% from the latest price. エアコン 取り付け 全国Web5 rows · See BioXcel Therapeutics, Inc. (BTAI) stock analyst estimates, including earnings and revenue, ... エアコン取り付け 兵庫WebOct 14, 2024 · BTAI 0.00% 73 See BTAI Report Wall Street is positive on BioXcel Therapeutics Inc ( BTAI ). On average, analysts give BioXcel Therapeutics Inc a Strong Buy rating. The average price target is $101.375, which means analysts expect the stock to climb by 251.51% over the next twelve months. エアコン 取り付け 出雲WebMar 17, 2024 · View BTAI revenue estimates and earnings estimates, as well as in-depth … エアコン取り付け 優良業者 神奈川WebApr 14, 2024 · Harmonic Inc. (NASDAQ:HLIT – Get Rating) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $15.86 and last traded at $15.80, with a volume of 786798 shares trading hands. The stock had previously closed at $15.51. Wall Street Analysts Forecast Growth A number of research firms […] palkiper commercial real estate servicesWebAnalysts Are Bullish on Top Healthcare Stocks: Bioxcel Therapeutics (BTAI), … palko decision